关注
Ibrahim H. Eissa
Ibrahim H. Eissa
Professor, Faculty of pharmacy, Al-Azhar University
在 azhar.edu.eg 的电子邮件经过验证
标题
引用次数
引用次数
年份
Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor
AA Al-Karmalawy, MA Dahab, AM Metwaly, SS Elhady, EB Elkaeed, ...
Frontiers in Chemistry 9, 661230, 2021
1572021
Design, synthesis and anticancer evaluation of thieno [2, 3-d] pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers
SA Elmetwally, KF Saied, IH Eissa, EB Elkaeed
Bioorganic chemistry 88, 102944, 2019
1422019
Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4 (3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers
HA Mahdy, MK Ibrahim, AM Metwaly, A Belal, ABM Mehany, ...
Bioorganic Chemistry 94, 103422, 2020
1312020
Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene) thiazolidin-2-ylidene) amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and …
WM Eldehna, MF Abo-Ashour, A Nocentini, P Gratteri, IH Eissa, M Fares, ...
European journal of medicinal chemistry 139, 250-262, 2017
1272017
Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR‐2 inhibitors
AGA El‐Helby, H Sakr, IH Eissa, H Abulkhair, AA Al‐Karmalawy, K El‐Adl
Archiv der Pharmazie 352 (10), 1900113, 2019
1222019
Design, synthesis and anticancer evaluation of 1H-pyrazolo [3, 4-d] pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers
AA Gaber, AH Bayoumi, AM El-Morsy, FF Sherbiny, ABM Mehany, ...
Bioorganic chemistry 80, 375-395, 2018
1202018
Design, synthesis, molecular modeling and biological evaluation of novel 1H-pyrazolo [3, 4-b] pyridine derivatives as potential anticancer agents
IH Eissa, AM El-Naggar, MA El-Hashash
Bioorganic chemistry 67, 43-56, 2016
1202016
Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors
MK Ibrahim, MS Taghour, AM Metwaly, A Belal, ABM Mehany, ...
European journal of medicinal chemistry 155, 117-134, 2018
1082018
Discovery of new pyrimidine-5-carbonitrile derivatives as anticancer agents targeting EGFR WT and EGFR T790M
AA Nasser, IH Eissa, MR Oun, MA El-Zahabi, MS Taghour, A Belal, ...
Organic & biomolecular chemistry 18 (38), 7608-7634, 2020
1052020
Traditional ancient Egyptian medicine: A review
AM Metwaly, MM Ghoneim, IH Eissa, IA Elsehemy, AE Mostafa, ...
Saudi journal of biological sciences 28 (10), 5823-5832, 2021
1042021
New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies
H Elkady, A Elwan, HA El-Mahdy, AS Doghish, A Ismail, MS Taghour, ...
Journal of enzyme inhibition and medicinal chemistry 37 (1), 403-416, 2022
1032022
Benzoxazole/benzothiazole‐derived VEGFR‐2 inhibitors: design, synthesis, molecular docking, and anticancer evaluations
AGA El‐Helby, H Sakr, IH Eissa, AA Al‐Karmalawy, K El‐Adl
Archiv Der Pharmazie 352 (12), 1900178, 2019
902019
Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors
KM El-Gamal, AM El-Morsy, AM Saad, IH Eissa, M Alswah
Journal of Molecular Structure 1166, 15-33, 2018
862018
Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4(3H)-one derivatives as potential PPARγ and SUR agonists
MK Ibrahim, IH Eissa, MS Alesawy, AM Metwaly, MM Radwan, ...
Bioorganic & medicinal chemistry 25 (17), 4723-4744, 2017
862017
Discovery of thieno [2, 3-d] pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents
SA El-Metwally, MM Abou-El-Regal, IH Eissa, ABM Mehany, HA Mahdy, ...
Bioorganic Chemistry 112, 104947, 2021
852021
Comprehensive virtual screening of the antiviral potentialities of marine polycyclic guanidine alkaloids against SARS-CoV-2 (COVID-19)
A El-Demerdash, AM Metwaly, A Hassan, TM Abd El-Aziz, EB Elkaeed, ...
Biomolecules 11 (3), 460, 2021
822021
Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents
MA El-Zahabi, H Sakr, K El-Adl, M Zayed, AS Abdelraheem, SI Eissa, ...
Bioorganic chemistry 104, 104218, 2020
822020
Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPARγ and SUR agonists
MK Ibrahim, IH Eissa, AE Abdallah, AM Metwaly, MM Radwan, ...
Bioorganic & medicinal chemistry 25 (4), 1496-1513, 2017
792017
Design, synthesis, docking, DFT, MD simulation studies of a new nicotinamide-based derivative: In vitro anticancer and VEGFR-2 inhibitory effects
EB Elkaeed, RG Yousef, H Elkady, IMM Gobaara, BA Alsfouk, DZ Husein, ...
Molecules 27 (14), 4606, 2022
782022
Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2, 4-dione derivatives targeting VEGFR-2 enzyme
K El-Adl, AGA El-Helby, H Sakr, IH Eissa, SSA El-Hddad, FMIA Shoman
Bioorganic chemistry 102, 104059, 2020
772020
系统目前无法执行此操作,请稍后再试。
文章 1–20